IL-15与CD40激进抗体协同作用,诱导对膀癌的持久免疫力
Jeffrey L Wong1,2, Patrick Smith1, Juan Angulo-Lozano1
1Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065.
概括
将CD40激动剂与IL-15结合起来可以增强膀癌的抗瘤免疫力. 这种策略利用树突细胞来促进CD8 T细胞的反应,为患者提供了一个有前途的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- CD40激动剂在癌症免疫治疗中表现有前途,但面临毒性和疗效挑战.
- 优化CD40向策略,包括组合疗法,对于改善临床结果至关重要.
- 需要进一步阐明IL-15途径在膀癌中CD40激动作用的有效性中的作用.
研究的目的:
- 调查内源性IL-15通路在膀癌中CD40激动的治疗活性中的作用.
- 探索结合抗CD40主体抗体与IL-15以增强抗瘤免疫反应的潜力.
- 为了验证这些研究结果在人性化的免疫能力高的正管膀瘤模型中.
主要方法:
- 在膀癌患者样本中分析IL-15和IL-15Rα表达.
- 在人性化免疫能力较强的小鼠中利用正确的膀瘤模型.
- 用抗CD40主体抗体和外源IL-15.5进行联合治疗.
主要成果:
- CD40激动性高调转呈IL-15/IL-15Rα复合体,特别是由树突细胞 (DCs).
- 这种上调与激活的CD8 T细胞的增加存在有关.
- 联合抗CD40和IL-15治疗在临床前模型中治疗性增强了抗瘤反应.
结论:
- 在膀癌中,IL-15途径是调解抗瘤CD40激动剂反应的组成部分.
- 与Fc优化的抗CD40抗体和IL-15向剂的联合治疗显示出显著的治疗潜力.
- 这些发现支持联合抗CD40和基于IL-15的疗法用于膀癌治疗的临床评估.
相关概念视频
01:27Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K